Richard Dana Ono Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard Dana Ono.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard Dana Ono. Richard Dana Ono is Director in HedgePath Pharmaceuticals, Inc. ($HPPI) and Director in Lipocine Inc. ($LPCN).
Latest Insider Trading Transactions of Richard Dana Ono
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28 2020 | HPPI | Inhibitor Therapeu ... | Ono Richard Dana | Director | Option Exercise | A | 0.03 | 754,839 | 23,400 | 754,839 | |
| Dec 17 2020 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 5,250 | 0 | 5,250 | |
| Dec 17 2020 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Buy | M | 0.00 | 5,250 | 0 | 10,125 | 4.9 K to 10.1 K (+107.69 %) |
| Jun 10 2020 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Option Exercise | A | 0.96 | 22,000 | 21,184 | 22,000 | |
| Mar 24 2020 | HPPI | Inhibitor Therapeu ... | Ono Richard Dana | Director | Option Exercise | A | 0.05 | 1,000,000 | 50,000 | 1,000,000 | |
| Jun 14 2019 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Option Exercise | A | 1.68 | 10,000 | 16,800 | 10,000 | |
| Feb 05 2019 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.08 | 657,895 | 50,000 | 657,895 | |
| Jun 28 2018 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Option Exercise | A | 1.33 | 20,000 | 26,600 | 20,000 | |
| Mar 15 2018 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.27 | 56,000 | 15,243 | 56,000 | |
| Mar 15 2018 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.27 | 253,000 | 68,867 | 253,000 | |
| Jan 02 2018 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 1,750 | 0 | 5,250 | |
| Jan 02 2018 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Sell | S | 3.47 | 875 | 3,033 | 4,875 | 5.8 K to 4.9 K (-15.22 %) |
| Jan 02 2018 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Buy | M | 0.00 | 1,750 | 0 | 5,750 | 4 K to 5.8 K (+43.75 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 150,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Payment of Exercise | F | 0.34 | 59,400 | 20,196 | 453,000 | 512.4 K to 453 K (-11.59 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Buy | M | 0.00 | 150,000 | 0 | 512,400 | 362.4 K to 512.4 K (+41.39 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Payment of Exercise | F | 0.34 | 118,800 | 40,392 | 362,400 | 481.2 K to 362.4 K (-24.69 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Buy | M | 0.00 | 300,000 | 0 | 481,200 | 181.2 K to 481.2 K (+165.56 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Payment of Exercise | F | 0.34 | 118,800 | 40,392 | 181,200 | 300 K to 181.2 K (-39.60 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Buy | M | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
| Jan 30 2017 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Option Exercise | A | 0.00 | 7,000 | 0 | 7,000 | |
| Jul 06 2016 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.24 | 150,000 | 36,000 | 150,000 | |
| Jul 06 2016 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
| Aug 18 2015 | HPPI | HedgePath Pharmace ... | Ono Richard Dana | Director | Option Exercise | A | 0.00 | 300,000 | 0 | 300,000 | |
| Jun 17 2015 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Option Exercise | A | 7.29 | 20,000 | 145,800 | 30,000 | |
| Nov 19 2014 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Buy | P | 5.14 | 4,000 | 20,560 | 4,000 | 0 to 4 K |
| Jan 08 2014 | LPCN | Lipocine Inc. | Ono Richard Dana | Director | Option Exercise | A | 8.25 | 10,000 | 82,500 | 10,000 |
Page: 1